PHARMAC Mark 2: towards agreed solutions?
Bosanquet
N
N
D003363:Cost Control; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D005252:Fees, Pharmaceutical; D006801:Humans; D009520:New Zealand; D011907:Rate Setting and Review / Q000379:methods* / Q000458:organization & administration